Frasers Centrepoint Trust – Falling tenant sales hindrance to healthier reversions January 22, 2019 764

PSR Recommendation: NEUTRAL Status: Maintained
Last Close Price: S$2.22 Target Price: S$2.21
  • 1Q19 NPI and DPU in line with our forecast. Improved NPI margins for Causeway Point and Changi City Point (CCP), with the latter performing exceptionally well.
  • Secured refinancing and prepayment of certain 2019 borrowings and 2020 debt.
  • Waning rental reversions for CCP and Northpoint North Wing. Flat same-store tenant sales growth during the Sep-Nov 2018 period, declining in excess of -1% YoY.
  • Maintain Neutral with unchanged TP of S$2.21.

The Positives

+ Improved NPI margins for CWP and CCP. Causeway Point (CWP) and Changi City Point (CCP) recorded higher NPI margins YoY, the latter of which performed exceptionally well (+12.7% YoY increase in revenue in comparison to the +2.7% YoY increase in expenses) due to the progressive tenant reconfiguration of the addition of more outlet tenants, as well as the heightened positioning of the mall on the back of the enhanced connectivity from the opening of Downtown Line 3 (one year since its opening in Oct 2017).

+ Secured refinancing and prepayment of certain 2019 borrowings and 2020 debt. FCT had secured commitments for the refinancing and prepayment of S$190mn borrowings – these are for the S$60mn MTN (due April 2019), S$60mn of unsecured bank borrowings (due June 2019), and the pre-payment of $70mn of secured bank borrowing (due Dec 2019 (FY2020)). It is intended to term out the remaining S$102mn of unsecured bank borrowings expiring in FY2019, in due course.

The Negatives

– Waning rental reversions for CCP and NPNW. Just over half of CCP’s and close to a third of NPNW’s expiring leases (by GRI) for FY2019 had been renewed in this first quarter alone, albeit on lower reversions (QoQ basis) of -1.3% (4Q18: 0.5%) and 1.9% (4Q18: 2.4%), respectively.

– Flat same-store tenant sales growth. Tenant sales (excl. NPNW) in the Sep-Nov 2018 period declined in excess of -1% YoY. On the same note, occupancy cost inched up to 16.6% for FY18 – this figure has crept up steadily over the past three years from 15.3% in FY15, in part due to NPNW’s AEI.

Outlook

The Manager expressed confidence that healthy reversions will continue to be clocked for CCP, despite the opening of Changi Jewel (Jewel) in March 2019, which is one train stop away. However the Manager acknowledged that there could a temporary adverse impact on sales and footfall for CCP, but also took note that the positioning of Jewel (said to comprise a higher proportion of SMEs than any of the malls in FCT’s portfolio) would be different than that of CCP.

Construction for the $15mn AEI (underground pedestrian link) at CWP will take place from end-Feb to Dec 2019, and some downtime in terms of temporal loss in occupancy and footfall is expected during this time period. However the addition of this underpass will bring about improved connectivity and expand the catchment area for CWP in the long run.

Separately, it was announced that the CEO of the Manager of FCT, Dr. Chew Tuan Chiong, will step down by end-2019 after a decade with the Group, and that his successor will be announced in due course.

Maintain NEUTRAL with unchanged TP of S$2.21

Our target price translates to a FY19e yield of 5.3% and a P/NAV of 1.09.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!